Mark Smithyes, president of Labtician Théa, highlights the company’s ambition to become the leader and preferred partner to optometrists and ophthalmologists in Canada by launching products from Laboratoires Théa’s innovative portfolio and building on Labtician Ophthalmics’ excellent reputation.
Mark, what were the decisive pinpoints behind the joint venture between Labtician Ophthalmics and Laboratoires Théa?
"Canada has enormous potential not just to contribute to the global life sciences landscape as we do now but more importantly to be a leader."
